During a live event, Mark J. Fesler, MD, and participants discussed selection and timing of initiation of JAK inhibitor ...

Adults with MI and ADHD exhibit similar cardiometabolic profiles but are 53% more likely to smoke and show double the ...

These findings highlight specific patient groups who may benefit from targeted screening for anal HPV and anal cancer,” said lead study author Dr. Ashley Robinson.

During a live event, Mark J. Fesler, MD, and participants discuss next steps for a 68-year-old patient with intermediate-risk myelofibrosis.

CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder ...

Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due ...

Among patients who received empagliflozin ... in future trials to reassess the benefit-risk ratio across different risk profiles within the population with T1D.” Disclosure: Multiple study ...

Endometrial cancer is the most common gynecological cancer in high-developed countries, most often affecting women after menopause ...

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with ...

Recurrence in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer is common, and there have been a lack of alternative treatments to TURBT.

So, I declined to use it, figuring the risk was too great ... and used by enough patients to adequately know what their ...